Progenics Pharmaceuticals, Inc. (PGNX) Reports In-Line Q2 EPS

August 9, 2013 7:31 AM

Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) reported Q2 EPS of ($0.24) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found